Evolving strategies for the management of non-palpable breast abnormalities.
Increased public and professional awareness has resulted in more women obtaining mammograms. As a result, the surgeon is often called on to diagnose and treat occult breast lesions. The development of new diagnostic modalities has changed the way such breast lesions are approached. Management decisions are made in the context of new pressures applied by the growing managed care imperative and increased mediocolegal exposure. In this review, we establish guidelines for the management of non-palpable breast abnormalities that place the welfare of the patient first.
Kurtzman
S H
SH
Department of Surgery, University of Connecticut School of Medicine, Farmington, USA.
MacGillivray
D C
DC
Deckers
P J
PJ
D000328:Adult; D001707:Biopsy, Needle; D001941:Breast Diseases / Q000175:diagnosis* / Q000628:therapy; D001943:Breast Neoplasms / Q000175:diagnosis*; D002114:Calcinosis / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods; D008327:Mammography; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis*; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D018570:Risk Assessment; D013238:Stereotaxic Techniques